scholarly journals Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes

2017 ◽  
Vol 22 (7) ◽  
pp. 577-586 ◽  
Author(s):  
Priya Bhagwat ◽  
Ighovwerha Ofotokun ◽  
Grace A McComsey ◽  
Todd T Brown ◽  
Carlee Moser ◽  
...  
2018 ◽  
Vol 5 (11) ◽  
Author(s):  
Priya Bhagwat ◽  
Ighovwerha Ofotokun ◽  
Grace A McComsey ◽  
Todd T Brown ◽  
Carlee Moser ◽  
...  

Abstract Background This study investigates the association of clinical and demographic predictors with abdominal fat gain, measured using waist circumference (WC) and self-reported abdominal size. Methods We analyzed data from ACTG A5257, a clinical trial that randomized treatment-naïve HIV-infected participants to 1 of 3 antiretroviral regimens: raltegravir (RAL) or the protease inhibitors (PIs) atazanavir/ritonavir (ATV/r) or darunavir/ritonavir (DRV/r), each in combination with tenofovir disoproxil fumarate/emtricitabine. Associations of treatment and baseline/demographic characteristics with 96-week WC change were assessed using repeated-measures models. Ordinal logistic regression was used to examine the associations of predictors with week 96 self-reported abdominal changes. Results The study population (n = 1809) was 76.0% male and predominantly black non-Hispanic (41.9%) and white non-Hispanic (34.1%). Mean baseline WC was 90.6 cm, with an average 96-week increase of 3.4 cm. WC increases were higher in the RAL arm compared with DRV/r (P = .0130). Females experienced greater increases in WC on RAL vs ATV/r than males (P = .0065). Similarly, a larger difference in WC change was found for RAL vs DRV/r for black vs nonblack individuals (P = .0043). A separate multivariable model found that in addition to the treatment regimen, higher baseline viral load and lower CD4+ were also associated with WC increases. Conclusions With antiretroviral therapy initiation, higher WC increases in the RAL arm compared with PIs were more pronounced in female and black participants, and a more advanced baseline HIV disease state was a strong predictor of larger abdominal increases. Understanding factors predisposing individuals to abdominal fat gain could inform health management after therapy initiation.


PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e32213 ◽  
Author(s):  
Tina Landsvig Berentzen ◽  
Lars Ängquist ◽  
Anna Kotronen ◽  
Ronald Borra ◽  
Hannele Yki-Järvinen ◽  
...  

2014 ◽  
Vol 19 (4) ◽  
pp. 666-678 ◽  
Author(s):  
Monica da Silva ◽  
Meridith Blevins ◽  
C. William Wester ◽  
José Manjolo ◽  
Eurico José ◽  
...  

AIDS ◽  
2013 ◽  
Vol 27 (6) ◽  
pp. 867-877 ◽  
Author(s):  
Timothy L. Hayes ◽  
David M. Asmuth ◽  
J. William Critchfield ◽  
Thomas H. Knight ◽  
Bridget E. McLaughlin ◽  
...  

AIDS ◽  
2007 ◽  
Vol 21 (13) ◽  
pp. 1731-1738 ◽  
Author(s):  
Todd T Brown ◽  
Haitao Chu ◽  
Zhaojie Wang ◽  
Frank J Palella ◽  
Lawrence Kingsley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document